Healthcare Sector Articles Healthcare Sector Articles - Page 2 May 12, 2026 11:00 AM ETHims & Hers Stock Plunges After Q1 Miss: Is the GLP-1 Pivot Enough to Fuel a Recovery?Jessica MitacekNYSE:HIMSNYSE:NVORead Hims & Hers Stock Plunges After Q1 Miss: Is the GLP-1 Pivot Enough to Fuel a Recovery?May 10, 2026 6:50 AM ET3 Healthcare Stocks Set to Benefit From the One Big Beautiful BillChris MarkochNYSE:UNHNYSE:HUMNYSE:CVSRead 3 Healthcare Stocks Set to Benefit From the One Big Beautiful BillMay 8, 2026 9:10 AM ETHims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in FocusJessica MitacekNYSE:HIMSNYSE:NVORead Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in FocusMay 7, 2026 8:05 AM ETWhat the FDA's Latest Proposal Means for Lilly, Novo, and HimsLeo MillerNYSE:LLYNYSE:NVONYSE:HIMSRead What the FDA's Latest Proposal Means for Lilly, Novo, and HimsMay 5, 2026 10:25 AM ET3 Reasons Analysts Love DexComNathan ReiffNASDAQ:DXCMNYSE:MDTRead 3 Reasons Analysts Love DexComMay 2, 2026 6:45 AM ETThe Most Important Part of These 3 Big Pharma Earnings Reports Wasn’t the BeatJessica MitacekNYSE:ABBVNYSE:AZNNYSE:GSKRead The Most Important Part of These 3 Big Pharma Earnings Reports Wasn’t the BeatMay 1, 2026 11:05 AM ETLilly's Double-Beat Widens the GLP-1 Gap—And a New Pill Could Make It PermanentNathan ReiffNYSE:LLYNYSE:NVORead Lilly's Double-Beat Widens the GLP-1 Gap—And a New Pill Could Make It PermanentMay 1, 2026 8:45 AM ETViking Therapeutics Faces Timeline Risk—But Upside Could Be HugeChris MarkochNASDAQ:VKTXNYSE:LLYNYSE:NVORead Viking Therapeutics Faces Timeline Risk—But Upside Could Be HugeApril 29, 2026 12:50 PM ETAbbVie Fires Healthy Trend-Following Signal: Is a Rebound Ahead?Thomas HughesNYSE:ABBVNYSE:ABTRead AbbVie Fires Healthy Trend-Following Signal: Is a Rebound Ahead?April 28, 2026 7:55 AM ETAmazon Takes a Bite Out of Hims: What Its GLP-1 Entrance MeansLeo MillerNYSE:HIMSNYSE:LLYNYSE:NVORead Amazon Takes a Bite Out of Hims: What Its GLP-1 Entrance MeansApril 27, 2026 9:15 AM ETThese 3 Psychedelic Stocks Activated After Trump's Executive OrderNathan ReiffNASDAQ:CMPSNASDAQ:ATAINASDAQ:MNMDRead These 3 Psychedelic Stocks Activated After Trump's Executive OrderApril 27, 2026 5:05 AM ET3 Biotech Stocks That Could Benefit from the Patent CliffChris MarkochNASDAQ:NTLANASDAQ:BEAMNASDAQ:CRSPRead 3 Biotech Stocks That Could Benefit from the Patent Cliff Page 2 of 2 ‹ Most Recent12 More Articles by TopicArticle TopicsAll ArticlesAIAnalyst RatingsBiotechCommunication Services SectorCongressional TradingConsumer Discretionary SectorConsumer Staples SectorDefenseDividendEarningsElectric VehicleEnergy SectorETFFinance SectorHealthcare SectorIndustrial SectorInsider TradingInvestor EducationIPOMacroMaterials SectorMergers & AcquisitionsQuantum ComputingRare Earth MineralsReal Estate SectorSemiconductorShort InterestSpaceStock IdeaStock MarketTechnology SectorUtilities SectorInstant Alert TopicsAll Instant AlertsAnalystCongressional TradesConsensusCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
